Moleculin Biotech, Inc. recorded an outflow of $22.7M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Moleculin Biotech, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MBRX Free Cash Flow by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
MBRX Free Cash Flow by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Moleculin Biotech, Inc. financials
Frequently Asked Questions
Moleculin Biotech, Inc. recorded an outflow of $22.7M in free cash flow in fiscal year 2025.
Moleculin Biotech, Inc. (MBRX) reported an outflow of $23.9M in free cash flow in fiscal year 2024 and an outflow of $22.7M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Moleculin Biotech, Inc. (MBRX) reported on that line in every period on record.